Liraglutide studies: 1,219 papers with results
Page 24 of 25
- Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States.
Liu L · Journal of managed care & specialty pharmacy · 2025
Not a test of Liraglutide alone · 12 results
- Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion: A Propensity-Matched Analysis.
Vatsia SK · Clinical spine surgery · 2025
Not a test of Liraglutide alone · 8 results
- Role of GLP1-RA in Optimizing Weight Loss Post-Bariatric Surgery: A Systematic Review and Meta-Analysis.
Pereira M · Obesity surgery · 2024
Not a test of Liraglutide alone · 2 results
- Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Intima-Media Thickness: Systematic Review and Meta-Analysis.
Akbari A · Journal of diabetes research · 2024
Not a test of Liraglutide alone · 2 results
- Weight Loss Induces Changes in Vitamin D Status in Women With Obesity But Not in Men: A Randomized Clinical Trial.
Holt R · The Journal of clinical endocrinology and metabolism · 2025
Not a test of Liraglutide alone · 2 results
- GLP-1 receptor agonists for treating obesity without diabetes: A systematic review and meta-analysis of economic evaluations.
Dhippayom T · Diabetes, obesity & metabolism · 2026
Not a test of Liraglutide alone · 4 results
- A Pair of Siblings With Wolfram Syndrome: A Review of the Literature and Treatment Options.
Png D · Journal of investigative medicine high impact case reports · 2023
Not a test of Liraglutide alone · 2 results
- Cost-effectiveness analysis of once-weekly semaglutide vs. once-daily liraglutide administered subcutaneously in patients with overweight and obesity: a decision analysis.
Alshahawey M · European review for medical and pharmacological sciences · 2024
Not a test of Liraglutide alone · 4 results
- Glucagon-like peptide-1 receptor agonists for the treatment of opioid use disorders: a systematic review.
Au HCT · Acta neuropsychiatrica · 2025
Not a test of Liraglutide alone · 2 results
- Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery.
Samuels JM · Diabetes, obesity & metabolism · 2024
Not a test of Liraglutide alone · 6 results
- Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study.
Anthony MS · Diabetes care · 2024
Not a test of Liraglutide alone · 6 results
- Pharmacogenetic interactions of medications administered for weight loss in adults: a systematic review and meta-analysis.
BouSaba J · Pharmacogenomics · 2023
Not a test of Liraglutide alone · 2 results
- Can obesity exacerbate hyperinsulinaemia in the presence of the mutation of an insulin receptor gene?
Calcaterra V · Clinical obesity · 2023
Not a test of Liraglutide alone · 2 results
- High-Dose Liraglutide and SGLT2 Inhibitor: A Promising Combination.
Chua MWJ · Clinics and practice · 2021
Not a test of Liraglutide alone · 2 results
- Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease.
Nakhleh A · Journal of clinical medicine · 2025
Not a test of Liraglutide alone · 7 results
- Surrogate endpoint evaluation using data from one large global randomized controlled trial.
Geybels M · BMC medical informatics and decision making · 2021
Not a test of Liraglutide alone · 2 results
- The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis.
Zhang J · Nagoya journal of medical science · 2021
Not a test of Liraglutide alone · 2 results
- High BMI z-Scores from Different Growth References Are Not Comparable: An Example from a Weight Management Trial with an Anti-Obesity Medication in Pubertal Adolescents with Obesity.
Hales CM · Childhood obesity (Print) · 2025
Not a test of Liraglutide alone · 2 results
- Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission.
Figueredo Y · Cureus · 2023
Not a test of Liraglutide alone · 4 results
- HNF1B-MODY (MODY-5): a rare form of diabetes with multisystemic features-two case reports.
Carvalho T · Frontiers in endocrinology · 2026
Not a test of Liraglutide alone · 2 results
- Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis.
Pisani D · Endocrine · 2026
Not a test of Liraglutide alone · 6 results
- Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application.
Tong LH · Journal of chromatography. A · 2026
Not a test of Liraglutide alone · 13 results
- Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.
Ren L · Diabetes, obesity & metabolism · 2026
Not a test of Liraglutide alone · 8 results
- Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review.
Puspitasari IM · Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
Not a test of Liraglutide alone · 10 results
- Potential Drug Interaction Between Liraglutide and Clonazepam: A Case Report.
Kheradmand A · Case reports in psychiatry · 2025
Not a test of Liraglutide alone · 2 results
- Comparison of low-dose liraglutide use versus other GLP-1 receptor agonists in patients without type 2 diabetes.
Wittbrodt ET · The American journal of managed care · 2018
Not a test of Liraglutide alone · 2 results
- Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes.
Storgaard H · Diabetes, obesity & metabolism · 2017
Not a test of Liraglutide alone · 2 results
- A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults.
McGowan B · Nature medicine · 2025
Not a test of Liraglutide alone · 13 results
- Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review.
Halloum W · The journal of headache and pain · 2024
Not a test of Liraglutide alone · 1 result
- Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis.
Gaisl T · Sleep medicine reviews · 2019
Not a test of Liraglutide alone · 1 result
- Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials.
Monami M · Journal of endocrinological investigation · 2017
Not a test of Liraglutide alone · 2 results
- Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.
Giorda CB · Endocrine · 2015
Not a test of Liraglutide alone · 1 result
- Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study.
Sam S · Diabetes care · 2021
Not a test of Liraglutide alone · 1 result
- Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.
Xie Z · Frontiers in endocrinology · 2023
Not a test of Liraglutide alone · 15 results
- A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?
Docimo S Jr · Surgical endoscopy · 2024
Not a test of Liraglutide alone · 2 results
- Incremental cost-effectiveness of evidence-based non-surgical weight loss strategies.
Finkelstein EA · Clinical obesity · 2019
Not a test of Liraglutide alone · 1 result
- Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review.
Alsaqaaby MS · The lancet. Diabetes & endocrinology · 2024
Not a test of Liraglutide alone · 6 results
- Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression.
Wagner S · Molecular metabolism · 2023
Not a test of Liraglutide alone · 2 results
- Cost-effectiveness analysis of 4 GLP-1RAs in the treatment of obesity in a US setting.
Hu Y · Annals of translational medicine · 2022
Not a test of Liraglutide alone · 5 results
- Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome.
Kim YM · Annals of pediatric endocrinology & metabolism · 2020
Not a test of Liraglutide alone · 1 result
- Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review.
Stretton B · Internal medicine journal · 2023
Not a test of Liraglutide alone · 4 results
- Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude.
Squadrito F · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
Not a test of Liraglutide alone · 1 result
- Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.
Kim YJ · Frontiers in endocrinology · 2020
Not a test of Liraglutide alone · 1 result
- Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China.
Feng Z · Frontiers in pharmacology · 2023
Not a test of Liraglutide alone · 11 results
- Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis.
Nomoto H · Pharmaceutics · 2023
Not a test of Liraglutide alone · 7 results
- Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Naïve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) Study.
Brooks-Worrell BM · Frontiers in immunology · 2021
Not a test of Liraglutide alone · 1 result
- The effect of obesity interventions on male fertility: a systematic review and meta-analysis.
Peel A · Human reproduction update · 2026
Not a test of Liraglutide alone · 1 result
- A Retrospective Observational Study Examining the Generalizability of Glucagon-Like Peptide 1 Receptor Agonist Cardiovascular Outcome Trials to the Real-World Population with Type 2 Diabetes in Spain: The REPRESENT Study.
Romera I · Advances in therapy · 2022
Not a test of Liraglutide alone · 2 results
- Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review.
González-González JG · BMJ open · 2021
Not a test of Liraglutide alone · 1 result
- Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado.
DiStefano MJ · Journal of pharmaceutical policy and practice · 2025
Not a test of Liraglutide alone · 5 results